Canada Recalls Thousands of Cannabis Products Due to Labeling Errors and Intoxication Concerns
Health Canada has issued a recall of over 17,000 units of cannabis products due to labeling errors that may have caused intoxication in consumers. The affected products, including softgels and oil extracts, were sold in six provinces and the Yukon between December 2022 and July 2024.
The recalled products, which include Emprise CBN+CBD 50 mg softgels, NuLeaf Naturals 1800 mg full spectrum hemp multicannabinoid oil and oil softgels, and Ultra Plus 1200 mg multicannabinoid oil and Ultra Plus 750 mg multicannabinoid softgels, were found to contain significant amounts of the intoxicating cannabinoids hexahydrocannabinol (HHC) and tetrahydrocannabinol (THC). This is despite labeling that claimed the products contained less than 3 milligrams per unit for softgels or gram for oils.
As a result, some consumers have reported adverse reactions, including two reports received by iNaturally Organic Inc. and five reports received by Health Canada, as well as one complaint. Health Canada has urged consumers to immediately stop using the recalled products and return or dispose of them.
Consuming THC and HHC can lead to cannabis poisoning, which can cause a range of symptoms including chest pain, rapid heartbeat, nausea, vomiting, psychotic episodes, respiratory depression, severe anxiety, and panic attacks. In severe cases, it may require hospitalization.
Health Canada has conducted inspections of some of the affected products and found that each sample contained a significant quantity of HHC and THC. The agency has warned that the products contain intoxicating levels of these cannabinoids, making it impossible for consumers to make informed decisions about their cannabis use.
Consumers who have purchased the recalled products are advised to return or dispose of them immediately and to consult with a healthcare professional if they have experienced any adverse reactions.
